Literature DB >> 9300796

ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines.

T Litman1, D Nielsen, T Skovsgaard, T Zeuthen, W D Stein.   

Abstract

We have characterized the ATPase activity of a sensitive and five progressively daunorubicin resistant Ehrlich ascites tumor cell lines passaged in mice. For the nine different modulators of drug resistance that we have studied, the ATPase activity first rose with the modulator concentration and then declined. We analyzed the ATPase activity profiles in terms of an activation constant and an inhibition constant for each of the nine drugs and six cell lines. In this series of cell lines, the drug-stimulatable ATPase activity was directly proportional to the amount of P-glycoprotein. Pumping of daunorubicin was also correlated with the amount of P-glycoprotein, except that, for a highly passaged line more daunorubicin was pumped than could be accounted for by the content of P-glycoprotein. Between the 12th and the 36th passage an additional source of resistance emerged, which was not correlated with P-glycoprotein. Pumping of daunorubicin was negatively correlated with the cell volume for the different lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300796     DOI: 10.1016/s0925-4439(97)00025-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Morgan E Gibbs; Robert W Barnes; Arthur G Roberts
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

2.  Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.

Authors:  Clifford W Mason; Hazem E Hassan; Kang-Pil Kim; Jianjing Cao; Natalie D Eddington; Amy Hauck Newman; Pamela J Voulalas
Journal:  J Pharmacol Exp Ther       Date:  2010-03-12       Impact factor: 4.030

3.  Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.

Authors:  Nicolas Tournier; Wadad Saba; Sébastien Goutal; Philippe Gervais; Héric Valette; Jean-Michel Scherrmann; Michel Bottlaender; Salvatore Cisternino
Journal:  AAPS J       Date:  2015-02-26       Impact factor: 4.009

4.  Effect of pluronic P85 on ATPase activity of drug efflux transporters.

Authors:  Elena V Batrakova; Shu Li; Yili Li; Valery Yu Alakhov; Alexander V Kabanov
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

5.  The role of size and charge for blood-brain barrier permeation of drugs and fatty acids.

Authors:  Anna Seelig
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

6.  A novel screening strategy to identify ABCB1 substrates and inhibitors.

Authors:  Oliver von Richter; Hristos Glavinas; Peter Krajcsi; Stephanie Liehner; Beate Siewert; Karl Zech
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-29       Impact factor: 3.000

7.  Evidence for P-Glycoprotein Involvement in Cell Volume Regulation Using Coulter Sizing in Flow Cytometry.

Authors:  Jennifer Pasquier; Damien Rioult; Nadine Abu-Kaoud; Jessica Hoarau-Véchot; Matthieu Marin; Frank Le Foll
Journal:  Int J Mol Sci       Date:  2015-06-24       Impact factor: 5.923

8.  Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos.

Authors:  Stephan Fischer; Nils Klüver; Kathleen Burkhardt-Medicke; Mirko Pietsch; Anne-Marie Schmidt; Peggy Wellner; Kristin Schirmer; Till Luckenbach
Journal:  BMC Biol       Date:  2013-06-17       Impact factor: 7.431

9.  Novel Strategy to Fabricate PLA/Au Nanocomposites as an Efficient Drug Carrier for Human Leukemia Cells in Vitro.

Authors:  Jingyuan Li; Chen Chen; Xuemei Wang; Zhongze Gu; Baoan Chen
Journal:  Nanoscale Res Lett       Date:  2010-09-14       Impact factor: 4.703

10.  Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Robert W Barnes; Arthur G Roberts
Journal:  Biosci Rep       Date:  2016-01-28       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.